So it is clear that the AMPK/SIRT1/PGC-1α network is a critical energy-sensing signaling pathway and that AMPK activation will induce the concurrent deacetylation and phosphorylation of its downstream targets and relieve the susceptibility to IR-associated metabolic disorders [36]. The gene discussed is PPARGC1A; the disease is metabolic disease.